JCM-16021

ZhaoXiang Bian · Phase 2 active Small molecule

At a glance

Generic name	JCM-16021
Sponsor	ZhaoXiang Bian
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Efficacy and Safety of Chinese Medicine JCM-16021 for Diarrhea-predominant Irritable Bowel Syndrome (PHASE2, PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

JCM-16021 CI brief — competitive landscape report
JCM-16021 updates RSS · CI watch RSS
ZhaoXiang Bian portfolio CI